186 related articles for article (PubMed ID: 11550416)
21. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
[TBL] [Abstract][Full Text] [Related]
22. [Systemic sclerosis with renal involvement in a 15-year old girl diagnosed with lichen sclerosus].
Kniazewska M; Zmudzińska-Kitczak J; Urban K; Obuchowicz A; Wilk M; Rudka R
Pol Merkur Lekarski; 2001 Apr; 10(58):296-7. PubMed ID: 11434184
[TBL] [Abstract][Full Text] [Related]
23. [Systemic scleroderma].
Hunzelmann N
Hautarzt; 2013 Apr; 64(4):299-310; quiz 311-2. PubMed ID: 23576170
[TBL] [Abstract][Full Text] [Related]
24. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N
Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of scleroderma peripheral vascular disease.
Herrick A
Rheum Dis Clin North Am; 2008 Feb; 34(1):89-114; vii. PubMed ID: 18329535
[TBL] [Abstract][Full Text] [Related]
26. Early detection of scleroderma spectrum disorders in patients with Raynaud's phenomenon.
Takehara K; Soma Y; Ishibashi Y
Dermatologica; 1991; 183(3):164-8. PubMed ID: 1743381
[TBL] [Abstract][Full Text] [Related]
27. Unilateral limited scleroderma-like changes following formation of an arteriovenous fistula.
Roberts H; Curnow PA
Australas J Dermatol; 2007 Feb; 48(1):37-9. PubMed ID: 17222301
[TBL] [Abstract][Full Text] [Related]
28. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M
Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066
[TBL] [Abstract][Full Text] [Related]
29. Dystrophic calcifications and Raynaud's phenomenon in an eight-year old girl.
Grebeldinger SP; Tomić JM; Vijatov-Djurić GV; Radojcić BS; Vucković NM; Culafić JN
Srp Arh Celok Lek; 2014; 142(3-4):239-42. PubMed ID: 24839783
[TBL] [Abstract][Full Text] [Related]
30. Case report: insulin-dependent diabetes mellitus in childhood associated with scleroderma.
Polak M; Le Luyer B; Rybojab M; Czernichow P
Diabetes Metab; 1996 Jun; 22(3):192-6. PubMed ID: 8697307
[TBL] [Abstract][Full Text] [Related]
31. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
Henness S; Wigley FM
Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
[TBL] [Abstract][Full Text] [Related]
32. [A case of amyopathic dermatomyositis with systemic sclerosis sine scleroderma presenting abnormal vermiculation].
Kubo N; Sawayama Y; Okada K; Nakagawa Y; Asou Y; Nabeshima S; Otsuka T; Kashiwagi S; Hayashi J
Ryumachi; 2002 Aug; 42(4):676-81. PubMed ID: 12355862
[TBL] [Abstract][Full Text] [Related]
33. [Raynaud's phenomenon and sclerodermia].
Ezquerra Gadea J; López Larrayoz I; García Cores F; García Muñoz M
Aten Primaria; 2003 Jun; 32(1):60. PubMed ID: 12812693
[No Abstract] [Full Text] [Related]
34. [Systemic sclerosis].
Kleinert S; Tony HP; Kneitz C
Internist (Berl); 2006 Oct; 47(10):1051-61; quiz 1062. PubMed ID: 16972070
[TBL] [Abstract][Full Text] [Related]
35. The cardiac magnetic resonance in the diagnosis of cardiac Raynaud phenomenon in a patient with systemic sclerosis: case report and review of literature.
Quarta S; Galea N; Gigante A; Romaniello A; Rosato E; Carbone I
Expert Rev Clin Immunol; 2016; 12(3):251-5. PubMed ID: 26692357
[TBL] [Abstract][Full Text] [Related]
36. Prolonged improvement of Raynaud's phenomenon and scleroderma after recombinant tissue plasminogen activator therapy.
Fritzler MJ; Hart DA
Arthritis Rheum; 1990 Feb; 33(2):274-6. PubMed ID: 2106327
[TBL] [Abstract][Full Text] [Related]
37. [Raynaud's phenomenon and systemic scleroderma].
Fiessinger JN; Housset E
Rev Prat; 1975 May; 25(25):1989-92, 1997-8. PubMed ID: 1135587
[No Abstract] [Full Text] [Related]
38. Progressive systemic sclerosis sine scleroderma in a child presenting as nocturnal seizures and Raynaud's phenomenon.
Navon P; Halevi A; Brand A; Branski D; Rubinow A
Acta Paediatr; 1993 Jan; 82(1):122-3. PubMed ID: 8453211
[TBL] [Abstract][Full Text] [Related]
39. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
40. Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial.
Dziadzio M; Denton CP; Smith R; Howell K; Blann A; Bowers E; Black CM
Arthritis Rheum; 1999 Dec; 42(12):2646-55. PubMed ID: 10616013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
